2023/09/21 08:01:07 | |
---|---|
Price | |
19.756 EUR | |
Difference | -1.07% (-0.21) |
ISIN | NL0000009538 |
Symbol | PHIA |
Exchange | Hanover |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 17,927 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 19.756 EUR |
High | 19.756 EUR |
Low | 19.756 EUR |
Close (prev. day) | 19.97 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | 53 |
Related Options | - |
Date | Headline | Download | |
2023/09/08 |
![]() |
Global Equity Ratings |
![]() |
2023/08/22 |
![]() |
Global Equity Ratings |
![]() |
2023/08/17 |
![]() |
Global Equity Ratings |
![]() |
2023/08/09 |
![]() |
Global Equity Ratings |
![]() |
2023/07/21 |
![]() |
Global Equity Ratings |
![]() |
2023/09/21 08:01:07 | |
---|---|
Price | |
19.756 EUR | |
Difference | -1.07% (-0.21) |
ISIN | NL0000009538 |
Symbol | PHIA |
Exchange | Hanover |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 17,927 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 19.756 EUR |
High | 19.756 EUR |
Low | 19.756 EUR |
Close (prev. day) | 19.97 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +37.70% | +16.09% | -47.33% |
Perf (abs.) | +5.47 | +2.77 | -17.95 |
Beta | 0.85 | 1.15 | 0.95 |
Volatility | 29.48 | 38.62 | 34.11 |
Ø price 5 days | Ø volume 5 days (pcs.) | 19.968 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 20.089 EUR (13) |
Ø price 100 days | Ø volume 100 days (pcs.) | 19.253 EUR (31) |
Ø price 250 days | Ø volume 250 days (pcs.) | 16.351 EUR (34) |
YTD High | date | 20.900 EUR (2023/08/21) |
YTD Low | date | 13.325 EUR (2023/01/02) |
52 Weeks High | date | 20.900 EUR (2023/08/21) |
52 Weeks Low | date | 11.489 EUR (2022/11/04) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/09/21 | 17:35 | 19.514 EUR | 0.12 | 37 |
Vienna Stock Exchange | 2023/09/21 | 09:05 | 19.83 EUR | 0.00 | 3 |
Tradegate | 2023/09/21 | 22:26 | 19.30 EUR | 0.22 | 54 |
Stuttgart | 2023/09/21 | 20:39 | 19.35 EUR | 0.02 | 10 |
SIX Swiss Exchange | 2022/06/02 | 15:20 | 47.0683 CHF | 0.00 | 1 |
Munich | 2023/09/21 | 08:00 | 19.762 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2023/09/21 | 17:29 | 19.5955 EUR | 0.00 | 1 |
Hanover | 2023/09/21 | 08:01 | 19.756 EUR | 0.00 | 1 |
Hamburg | 2023/09/21 | 08:01 | 19.762 EUR | 0.00 | 1 |
Frankfurt | 2023/09/21 | 17:15 | 19.47 EUR | 0.02 | 14 |
FINRA other OTC Issues | 2023/09/21 | 20:28 | 20.358 USD | 0.00 | 3 |
Euronext Milan MTF Trading After Hours | 2023/09/20 | 18:53 | 19.48 EUR | 0.01 | 1 |
Euronext Milan MTF Global Equity Market | 2023/09/21 | 17:44 | 19.506 EUR | 0.02 | 10 |
Euronext Amsterdam | 2023/09/21 | 17:36 | 19.484 EUR | 39.61 | 6,467 |
Duesseldorf | 2023/09/21 | 19:30 | 19.32 EUR | 0.00 | 4 |
Berlin | 2023/09/21 | 21:52 | 19.302 EUR | 0.00 | 17 |
BX Swiss | 2023/09/20 | 18:00 | 19.205 CHF | 0.00 | 1 |
KONINKLIJKE PHILIPS NV |
- - |
Philips Center, Amstelplein 2 - 1096 BC Amsterdam |
Telefon: +31-20-597-77-77 |
Fax: + |
E-mail: - |
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands. |
Roy Jakobs | Chairman of Managing Board |
Edwin Paalvast | Member of Executive Committee |
Jan Kimpen | Member of Executive Committee |
Marnix van Ginneken | Member of Executive Committee |
Abhijit Bhattacharya | Member of Executive Committee |
Andy Ho | Member of Executive Committee |
Bert van Meurs | Member of Executive Committee |
Deeptha Khanna | Member of Executive Committee |
Derya Guzel | Member of Executive Committee |
Heidi Sichien | Member of Executive Committee |
Jako Eleveld | Member of Executive Committee |
Jeff DiLullo | Member of Executive Committee |
Julia Strandberg | Member of Executive Committee |
Karen Sörensen | Member of Executive Committee |
Nathalie Lam | Member of Executive Committee |
Nico Jonkers | Member of Executive Committee |
Sean Carney | Member of Executive Committee |
Shez Partovi | Member of Executive Committee |
Steve C. de Baca | Member of Executive Committee |
Willem Appelo | Member of Executive Committee |
Feike Sijbesma | Chairman of Supervisory Board |
A. Harrison | Member of Supervisory Board |
Paulus Stoffels | Member of Supervisory Board |
David Pyott | Member of Supervisory Board |
Hendrica Verhagen | Member of Supervisory Board |
Indra Krishnamurthy Nooyi | Member of Supervisory Board |
Mary Doherty | Member of Supervisory Board |
Peter D. Löscher | Member of Supervisory Board |
Sanjay Poonen | Member of Supervisory Board |
Sock Koong Chua | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer